ClearBridge Investments’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$46.9M Buy
823,998
+71,999
+10% +$4.2M 0.04% 327
2026
Q2
$43.7M Buy
751,999
+623,622
+486% +$33.9M 0.04% 345
2026
Q1
$7.46M Buy
+128,377
New +$6.97M 0.01% 504
2025
Q3
– Sell
-646,055
Closed -$21M – 742
2025
Q2
$21M Sell
646,055
-574,400
-47% -$18.8M 0.02% 411
2025
Q1
$46.1M Buy
1,220,455
+117,969
+11% +$9.43M 0.04% 317
2024
Q4
$90.2M Sell
1,102,486
-56,794
-5% -$5.64M 0.07% 242
2024
Q3
$132M Buy
1,159,280
+973,139
+523% +$87.7M 0.1% 191
2024
Q2
$14.1M Buy
+186,141
New +$12.7M 0.01% 495

Other funds holding PCVX

ClearBridge Investments's PCVX Position: Q3 2026 in Review

ClearBridge Investments increased its Vaxcyte (PCVX) stake by 9.6% in Q3 2026, buying an estimated $4.2M and bringing the position to 823,998 shares worth $46.9M. The position accounts for 0.04% of the portfolio, ranked #327.

ClearBridge Investments first reported a position in PCVX in Q2 2024 and has held it in 8 quarters since. The position peaked at $132M in Q3 2024. 356 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.

  • ClearBridge Investments held 823,998 shares of Vaxcyte worth $46.9M as of Q3 2026.
  • ClearBridge Investments bought 71,999 Vaxcyte shares in Q3 2026, an estimated $4.2M.
  • Vaxcyte made up 0.04% of ClearBridge Investments's portfolio in Q3 2026, its #327 holding.
  • ClearBridge Investments first reported a position in Vaxcyte in Q2 2024 and has held it in 8 quarters since.
  • ClearBridge Investments's Vaxcyte position peaked at $132M in Q3 2024.
  • 356 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.

Based on ClearBridge Investments's 13F filing for Q3 2026, filed 12 Nov 2026.